Psychosis patients waiting for NHS treatment
admin 16th January 2019 Uncategorised 0Over a thousand people with psychosis are still waiting for treatment on the NHS. More: Psychosis patients waiting for NHS treatment Source: News
read moreOver a thousand people with psychosis are still waiting for treatment on the NHS. More: Psychosis patients waiting for NHS treatment Source: News
read moreGoodbye, goodies. The International Federation of Pharmaceutical Manufacturers and Associations updated its guidelines for 2019 to eliminate all gifts from prescription drugmakers. More: No means no: Global pharma group bans any and all gifts to doctors Source: fierce
read moreTrue to its word, Acorda has moved its entire salesforce over from generics-plagued Ampyra to new Parkinson’s launch Inbrija. But it’s not relying solely on that team to get the ball rolling. More: Acorda's sales team switches gears to push
read moreGlaxoSmithKline has had a Shingrix shortage for months, but now Sen. Chuck Schumer is saying the government shutdown is making the situation worse. Fact is, the government reopening isn’t likely to have any effect on the vaccine’s scarcity. More: Sen.
read moreExelixis’ fast-growing Cabometyx just added another FDA approval. It can now treat liver cancer patients if Bayer’s Nexavar is no longer helpful, putting it in a field that’s already crowded with Bayer’s Stivarga and some checkpoint inhibitor stars. More: Exelixis
read moreU.S. Representatives Peter Welch and Francis Rooney are urging the Federal Trade Commission and Department of Justice to take a close look at Bristol-Myers’ $74 billion purchase of Celgene. Why? Past pharma mergers have spawned price hikes that hurt consumers,
read more© 1994 - 2024 B.M. Pharmaceuticals